Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Inhibitor of Pan Class-I Pi3k Induces Differentially Apoptotic Pathways in Acute Leukemia Cells: Shedding New Light on Nvp-Bkm120 Mechanism of Action Publisher Pubmed



Bashash D1 ; Safaroghliazar A1 ; Delshad M1 ; Bayati S2 ; Nooshinfar E3 ; Ghaffari SH4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Hematology and Blood banking, Faculty of Allied Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
  3. 3. Cancer Research Center, Shohada Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: International Journal of Biochemistry and Cell Biology Published:2016


Abstract

Complex interplay of intracellular signaling networks, spanning from the extracellular environment to the nucleus, orchestrate normal cell growth and survival. Dysregulation of such signals contributes to malignant transformation, thereby giving the cancer cells a survival advantage, but also could be exploited for new anticancer interventions. The aim of this study was to investigate the effects of pan class-I PI3K inhibitor NVP-BKM120 on two distinct acute leukemia cell lines, NB4 (with mutant p53) and Nalm-6 (with wild-type p53). Our data highlighted the efficacy of the inhibitor against APL and pre B ALL cell lines; however, we failed to find an obvious correlation between p53 status and the sensitivity of leukemic cells to NVP-BKM120. Real-time PCR analysis revealed a significant up-regulation of p53 target genes in Nalm-6 cells, indicating a p53-dependent mechanism involved in NVP-BKM120 cytotoxicity. On the other hand, cytotoxic effects in mutant p53-expressing NB4 cells seem to be mediated mostly by the inhibition of the PI3K/Akt/NF-κB axis. In conclusion, we suggest NVP-BKM120 induces apoptosis through p53-dependent and -independent mechanisms, indicating the potential application of the inhibitor in both wild-type and deficient p53-expressing leukemic cells. © 2016 Elsevier Ltd
Related Docs
1. Pi3k-Δ Inhibition Using Cal-101 Exerts Apoptotic Effects and Increases Doxorubicin-Induced Cell Death in Pre-B-Acute Lymphoblastic Leukemia Cells, Anti-Cancer Drugs (2017)
2. Novel Pan Pi3k Inhibitor-Induced Apoptosis in Apl Cells Correlates With Suppression of Telomerase: An Emerging Mechanism of Action of Bkm120, International Journal of Biochemistry and Cell Biology (2017)
3. Contributory Role of Micrornas in Anti-Cancer Effects of Small Molecule Inhibitor of Telomerase (Bibr1532) on Acute Promyelocytic Leukemia Cell Line, European Journal of Pharmacology (2019)
4. Inhibition of Tachykinin Nk1receptor Using Aprepitant Induces Apoptotic Cell Death and G1 Arrest Through Akt/P53 Axis in Pre-B Acute Lymphoblastic Leukemia Cells, European Journal of Pharmacology (2016)
5. Melatonin Promotes Ato-Induced Apoptosis in Mcf-7 Cells: Proposing Novel Therapeutic Potential for Breast Cancer, Biomedicine and Pharmacotherapy (2016)
6. Anti-Tumor Activity of Pi3k-Δ Inhibitor in Hematologic Malignant Cells: Shedding New Light on Resistance to Idelalisib, International Journal of Biochemistry and Cell Biology (2017)
7. The Long-Term Outcome and Efficacy of Pr1/Bcr-Abl Multipeptides Vaccination in Chronic Myeloid Leukemia: Results of a 7-Year Longitudinal Investigation, Iranian Journal of Blood and Cancer (2022)
Experts (# of related papers)
View all Related Experts
Seyed Hamidollah Ghaffari (7)
Mohammad Ahmadvand (1)